Sandor Victor 4
4 · Kymera Therapeutics, Inc. · Filed Jun 26, 2025
Insider Transaction Report
Form 4
Sandor Victor
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-25+16,000→ 16,000 totalExercise: $46.47Exp: 2035-06-24→ Common Stock (16,000 underlying)
Footnotes (1)
- [F1]The shares underlying this stock option shall vest in full upon the earlier to occur of (i) June 25, 2026 and (ii) the date of the next annual meeting of the Issuer's stockholders.